270 related articles for article (PubMed ID: 25296982)
1. Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission.
Ferreira SG; Gonçalves FQ; Marques JM; Tomé ÂR; Rodrigues RJ; Nunes-Correia I; Ledent C; Harkany T; Venance L; Cunha RA; Köfalvi A
Br J Pharmacol; 2015 Feb; 172(4):1074-86. PubMed ID: 25296982
[TBL] [Abstract][Full Text] [Related]
2. Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.
Martire A; Tebano MT; Chiodi V; Ferreira SG; Cunha RA; Köfalvi A; Popoli P
J Neurochem; 2011 Jan; 116(2):273-80. PubMed ID: 21062287
[TBL] [Abstract][Full Text] [Related]
3. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
Tozzi A; Tscherter A; Belcastro V; Tantucci M; Costa C; Picconi B; Centonze D; Calabresi P; Borsini F
Neuropharmacology; 2007 Nov; 53(6):783-9. PubMed ID: 17889039
[TBL] [Abstract][Full Text] [Related]
4. Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors.
Chiodi V; Ferrante A; Ferraro L; Potenza RL; Armida M; Beggiato S; Pèzzola A; Bader M; Fuxe K; Popoli P; Domenici MR
J Neurochem; 2016 Mar; 136(5):907-17. PubMed ID: 26526685
[TBL] [Abstract][Full Text] [Related]
5. Lack of presynaptic interaction between glucocorticoid and CB1 cannabinoid receptors in GABA- and glutamatergic terminals in the frontal cortex of laboratory rodents.
Bitencourt RM; Alpár A; Cinquina V; Ferreira SG; Pinheiro BS; Lemos C; Ledent C; Takahashi RN; Sialana FJ; Lubec G; Cunha RA; Harkany T; Köfalvi A
Neurochem Int; 2015 Nov; 90():72-84. PubMed ID: 26196379
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.
Domenici MR; Azad SC; Marsicano G; Schierloh A; Wotjak CT; Dodt HU; Zieglgänsberger W; Lutz B; Rammes G
J Neurosci; 2006 May; 26(21):5794-9. PubMed ID: 16723537
[TBL] [Abstract][Full Text] [Related]
7. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
Gerdeman G; Lovinger DM
J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
[TBL] [Abstract][Full Text] [Related]
8. A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation.
Tozzi A; de Iure A; Marsili V; Romano R; Tantucci M; Di Filippo M; Costa C; Napolitano F; Mercuri NB; Borsini F; Giampà C; Fusco FR; Picconi B; Usiello A; Calabresi P
PLoS One; 2012; 7(6):e38312. PubMed ID: 22715379
[TBL] [Abstract][Full Text] [Related]
9. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens.
Robbe D; Alonso G; Duchamp F; Bockaert J; Manzoni OJ
J Neurosci; 2001 Jan; 21(1):109-16. PubMed ID: 11150326
[TBL] [Abstract][Full Text] [Related]
10. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
Hájos N; Ledent C; Freund TF
Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A
Real JI; Simões AP; Cunha RA; Ferreira SG; Rial D
Eur J Neurosci; 2018 May; 47(9):1127-1134. PubMed ID: 29570875
[TBL] [Abstract][Full Text] [Related]
12. Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway.
Quiroz C; Luján R; Uchigashima M; Simoes AP; Lerner TN; Borycz J; Kachroo A; Canas PM; Orru M; Schwarzschild MA; Rosin DL; Kreitzer AC; Cunha RA; Watanabe M; Ferré S
ScientificWorldJournal; 2009 Nov; 9():1321-44. PubMed ID: 19936569
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids decrease corticostriatal synaptic transmission via an effect on glutamate uptake.
Brown TM; Brotchie JM; Fitzjohn SM
J Neurosci; 2003 Dec; 23(35):11073-7. PubMed ID: 14657164
[TBL] [Abstract][Full Text] [Related]
14. Is pharmacological neuroprotection dependent on reduced glutamate release?
Calabresi P; Picconi B; Saulle E; Centonze D; Hainsworth AH; Bernardi G
Stroke; 2000 Mar; 31(3):766-72; discussion 773. PubMed ID: 10700517
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic mGluRs Control the Duration of Endocannabinoid-Mediated DSI.
Colmers PLW; Bains JS
J Neurosci; 2018 Dec; 38(49):10444-10453. PubMed ID: 30355625
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia.
Mátyás F; Yanovsky Y; Mackie K; Kelsch W; Misgeld U; Freund TF
Neuroscience; 2006; 137(1):337-61. PubMed ID: 16289348
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
Huang CC; Lo SW; Hsu KS
J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.
Lopes LV; Cunha RA; Kull B; Fredholm BB; Ribeiro JA
Neuroscience; 2002; 112(2):319-29. PubMed ID: 12044450
[TBL] [Abstract][Full Text] [Related]
19. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.
Fukudome Y; Ohno-Shosaku T; Matsui M; Omori Y; Fukaya M; Tsubokawa H; Taketo MM; Watanabe M; Manabe T; Kano M
Eur J Neurosci; 2004 May; 19(10):2682-92. PubMed ID: 15147302
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum.
Daniel H; Rancillac A; Crepel F
J Physiol; 2004 May; 557(Pt 1):159-74. PubMed ID: 15034129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
